Browse the evidence

The blood lactate response was not different among the 3 rest interval conditions investigated.

Rest intervals do not significantly affect blood lactate levels, allowing flexibility in training protocols.

Human body weight is physiologically regulated and maintained within a relatively narrow range in most mammals, including humans.

Understanding body weight regulation can inform strategies for managing obesity.

Difficulties in achieving body weight loss and maintenance in obese subjects are partly due to physiological regulatory systems that resist weight loss.

Recognizing these physiological challenges can guide effective weight loss strategies.

Whey protein supplementation does not accelerate recovery of muscle function following eccentric exercise.

Practitioners should consider that whey protein may not be effective for recovery after eccentric exercise.

Muscle soreness, CK, and CRP showed a transient increase over time with no differences between groups.

Both whey protein and carbohydrates do not significantly affect muscle soreness or inflammation post-exercise.

Approximately 50% of diabetes remitters experience relapse at 20 years post-surgery.

Long-term monitoring is essential for patients who achieve remission to manage potential relapse.

Novel antidiabetic medications have demonstrated cardiovascular safety and benefits by reducing major adverse cardiac events, improving heart failure, and decreasing CVD-related mortality.

Practitioners should consider novel antidiabetic medications for patients with diabetes and coronary artery disease to improve cardiovascular outcomes.

Metformin shows CVD protective properties for DM-induced atherosclerotic and macrovascular complications.

Metformin should be considered as a first-line treatment for type 2 diabetes to protect against cardiovascular complications.

Insulin monotherapy for T2DM treatment increases the risk of major CV events and deaths from HF compared to metformin.

Practitioners should be cautious when prescribing insulin monotherapy for type 2 diabetes due to increased cardiovascular risks.

Restricting dietary carbohydrates does not offer a metabolic advantage for burning more calories to maintain lost weight.

Diet composition may not significantly impact energy expenditure for weight maintenance.

Blood flow restriction (BFR) without an associated exercise stimulus does not attenuate muscle size and strength losses during detraining.

BFR alone is insufficient to maintain muscle size and strength without ongoing exercise.

Both legs in the control (CON) and BFR conditions experienced significant reductions in quadriceps cross-sectional area (QCSA) and 1 repetition maximum (1RM) during the detraining period.

Detraining leads to significant losses in muscle size and strength, regardless of BFR application.

Post-exercise changes in proteins reflective of protein synthesis were similar between groups, though some mRNA exhibited exercise order-dependent responses.

Understanding the molecular responses can help tailor exercise programs for optimal protein synthesis.

No additive effect of the multi-ingredient supplement (SUPP) was detected on vastus lateralis muscle CSA.

The effects of multi-ingredient supplements may vary by muscle group, highlighting the need for targeted approaches.

Steep weight loss postintervention was associated with increased risk of mortality.

Healthcare providers should be cautious of rapid weight loss in older patients with diabetes.

An unconstrained post hoc-optimized branched algorithm best predicted criterion physical activity energy expenditure (PAEE) across a range of activities.

Practitioners can use the optimized algorithm for more accurate PAEE predictions in sedentary populations.

The performance of post hoc-optimized BA may be limited by heterogeneity in the daily living activities being performed.

Practitioners should consider activity diversity when using the algorithm for PAEE assessments.

Patients with higher baseline HbA1C had 9% reduced odds (OR, 0.91; 95% CI, 0.85–0.97) of experiencing weight loss.

Practitioners should monitor HbA1C levels as they may impact weight loss efforts in T2D patients.

Obesity is a global epidemic and a significant public health challenge.

Recognize obesity as a critical issue in public health.

Current anti-obesity medications (AOMs) include gastrointestinal lipase inhibitors, nutrient-stimulated hormone-based therapies, and emerging multi-receptor agonists.

Consider these AOMs in obesity treatment strategies.

The study incorporated investigations on genetic alleles associated with T2D and obesity.

Practitioners may consider genetic factors when addressing T2D and obesity in this population.

Obesity promotes the onset of atrial fibrillation (AF) through several pathways.

Understanding these pathways can help in developing targeted interventions for AF in obese patients.

Gastrointestinal tract adverse events were reported by 63.4% of participants on semaglutide.

Practitioners should monitor for gastrointestinal side effects in patients taking semaglutide.

The prevalence of obesity among youth with type 1 diabetes increased from 18.1% to 26.0% from 2008-2011 to 2020-2023.

Healthcare providers should be aware of the rising obesity rates in youth with T1D for better management strategies.